Valuation: Makers Laboratories Limited

Market Cap 89Cr 92.61L 81.14L 75.33L 69.22L 1.3Cr 1.32Cr 8.97Cr 3.51Cr 44Cr 3.48Cr 3.4Cr 151.05Cr P/E 2025
10.2x
P/E 2026 33.9x
Enterprise Value 84Cr 86.75L 76.01L 70.57L 64.84L 1.22Cr 1.24Cr 8.41Cr 3.29Cr 41Cr 3.26Cr 3.19Cr 141.5Cr EV / Sales 2025
0.67x
EV / Sales 2026 0.53x
Free-Float
32.66%
Yield 2025 *
-
Yield 2026 -
26/05 Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
10/02 Makers Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
07/11 Makers Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/25/29 CARE Affirms BBB+ Rating on Makers Laboratories' Long-Term Bank Financing; Outlook Stable MT
08/25/08 Makers Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
08/25/08 Makers Laboratories Returns to Consolidated Profit in Fiscal Q1; Shares Slide MT
26/25/26 Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
29/24/29 Makers Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
06/24/06 Makers Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
23/24/23 Makers Laboratories Gets Board Nod to Sell Mumbai, India Property to Ipca Laboratories MT
23/24/23 Makers Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
23/24/23 Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
15/24/15 Makers Laboratories Limited Announces the Resignation of Ms. Surbhi Sharma as Company Secretary / Compliance Officer, Effective March 13, 2024 CI
1 day-1.62%
1 week+1.47%
Current month+3.84%
1 month+2.47%
3 months+1.85%
6 months+26.21%
Current year+28.18%
1 week 148.2
Extreme 148.2
156
1 month 143
Extreme 143
168.5
Current year 112.1
Extreme 112.1
186.7
1 year 109
Extreme 109
186.7
3 years 98.05
Extreme 98.05
230
5 years 94
Extreme 94
238
10 years 23.2
Extreme 23.2
344.8
Manager TitleAgeSince
Chief Executive Officer 51 11/08/2011
Director of Finance/CFO 59 30/10/2017
Compliance Officer - 23/05/2024
Director TitleAgeSince
Director/Board Member 79 29/04/2009
Chairman 77 28/03/2019
Director/Board Member 51 11/08/2011
Change 5-day change 1-year change 3-year change Capi.($)
-1.62%+1.47%+1.00%+30.28% 94.32L
-0.96%-0.44%+15.79%+77.10% 4.89TCr
-1.00%-1.45%+58.71%+105.93% 3.57TCr
-1.21%-1.59%-3.37%+34.91% 1.2TCr
-1.47%-2.64%+17.72%+83.68% 1.18TCr
-0.37%-0.19%+36.48%+136.73% 895.32Cr
-0.77%+1.70%+46.91%-7.70% 691.16Cr
-0.34%-2.25%+14.42%+33.03% 677.9Cr
-1.88%-4.24%+1.95%+192.09% 656.98Cr
-2.47%-10.97%-31.86%+6.76% 580.84Cr
Average -1.20%-1.97%+15.77%+69.28% 1.43TCr
Weighted average by Cap. -1.05%-0.36%+25.19%+81.25%

Financials

2025 2026
Net sales 120.75Cr 1.25Cr 1.1Cr 1.02Cr 93.54L 1.76Cr 1.79Cr 12Cr 4.75Cr 59Cr 4.7Cr 4.6Cr 204.11Cr 140.87Cr 1.46Cr 1.28Cr 1.19Cr 1.09Cr 2.06Cr 2.09Cr 14Cr 5.54Cr 69Cr 5.48Cr 5.36Cr 238.12Cr
Net income 7.49Cr 8L 7L 6L 6L 10.93L 11.09L 75.22L 29.44L 3.67Cr 29.14L 28.51L 13Cr 2.35Cr 2L 2L 2L 2L 3L 3L 23.61L 9L 1.15Cr 9L 9L 3.97Cr
Net Debt 4.82Cr 5L 4L 4L 4L 7L 7L 48.4L 18.94L 2.36Cr 18.75L 18.34L 8.15Cr -5.65Cr -6L -5L -5L -4L -8L -8L -56.74L -22.21L -2.76Cr -21.98L -21.51L -9.55Cr
Logo Makers Laboratories Limited
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
Employees
114
Date Price Change Volume
22/26/22 ₹151.45 -1.62% 2,597
21/26/21 ₹153.95 +2.80% 281
20/26/20 ₹149.75 -0.03% 10
17/26/17 ₹149.80 -0.07% 805
16/26/16 ₹149.90 +0.44% 3,284
  1. Stock Market
  2. Stocks
  3. MAKERSL6 Stock